Lv62
3170 积分 2022-06-30 加入
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA
7个月前
已完结
Developing therapies for triple-negative breast cancer subtypes
8个月前
已完结
Trastuzumab Deruxtecan in Previously Treated Patients With HER2-Positive Metastatic Breast Cancer: Updated Survival Results From a Phase 2 Trial (DESTINY-Breast01)
10个月前
已完结
Expression of concern-Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study
10个月前
已完结
Pyrotinib in combination with first-line trastuzumab and docetaxel for patients with HER2-positive metastatic breast cancer: a new therapeutic option?
10个月前
已完结
Postoperative radiotherapy omission in selected patients with early breast cancer following preoperative breast MRI (PROSPECT): primary results of a prospective two-arm study
10个月前
已完结
Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer
11个月前
已完结
Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug conjugates (ADCs)
11个月前
已完结
Screening for breast cancer brain metastases - Authors' reply
1年前
已完结
中国乳腺癌规范诊疗质量控制指标 (2022版)
1年前
已完结
皖公网安备34019202002308
